0001140361-23-022950.txt : 20230504 0001140361-23-022950.hdr.sgml : 20230504 20230504161100 ACCESSION NUMBER: 0001140361-23-022950 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230502 FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mehta Piyush CENTRAL INDEX KEY: 0001408238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 23888802 MAIL ADDRESS: STREET 1: 825 EIGHTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 4 1 form4.xml X0407 4 2023-05-02 0001398659 Genpact LTD G 0001408238 Mehta Piyush C/O GENPACT LLC 521 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10175 true Senior Vice President and CHRO true Common Shares 2023-05-02 4 M 0 32500 19.35 A 241540 D Common Shares 2023-05-02 4 S 0 29929 43.7884 D 211611 D Common Shares 2023-05-02 4 S 0 2571 44.5447 D 209040 D Employee Stock Option (Right to Buy) 19.35 2023-05-02 4 M 0 32500 0 D 2023-05-30 Common Shares 32500 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.45 to $44.36. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.44 to $44.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. /s/ Thomas D. Scholtes, as Attorney-in-fact for Piyush Mehta 2023-05-04